Older cancer patients under-utilize advanced care planningJuly 10, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
AYAs with cancer receive aggressive EOL careJuly 10, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
NICE wants more info on PI3Kδ inhibitorJuly 8, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
PI3K inhibitors may promote cancer spreadJuly 4, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
PI3Kδ/γ inhibitor generates rapid responses in CLLJuly 2, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Radiation increases risk of death from CML, other leukemiasJuly 1, 2015Leukemia, Myelodysplasia, TransplantationALLCML
‘Radically different’ PI3Kδ inhibitor lacks hepatotoxicityJune 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
Nivolumab produces ‘dramatic’ responses in HLJune 25, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaCMLNon-Hodgkin Lymphoma
New insight into blood productionJune 21, 2015Leukemia, Myelodysplasia, TransplantationRelated IssuesTransplantation
Combo delays progression in relapsed CLLJune 19, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Dose reductions make ponatinib safer for CP-CMLJune 18, 2015Leukemia, Myelodysplasia, TransplantationCML
Drug may be ‘important treatment option’ for AMLJune 18, 2015Leukemia, Myelodysplasia, TransplantationAML
